Effective treatment of pulmonary adenocarcinoma harboring triple EGFR mutations of L858R, T790M, and -C797S by osimertinib, bevacizumab, and brigatinib combination therapy: a case report
about
Effective treatment of pulmonary adenocarcinoma harboring triple EGFR mutations of L858R, T790M, and -C797S by osimertinib, bevacizumab, and brigatinib combination therapy: a case report
description
im Januar 2018 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована у 2018
@uk
name
Effective treatment of pulmona ...... ination therapy: a case report
@en
Effective treatment of pulmona ...... ination therapy: a case report
@nl
type
label
Effective treatment of pulmona ...... ination therapy: a case report
@en
Effective treatment of pulmona ...... ination therapy: a case report
@nl
prefLabel
Effective treatment of pulmona ...... ination therapy: a case report
@en
Effective treatment of pulmona ...... ination therapy: a case report
@nl
P2093
P2860
P356
P1476
Effective treatment of pulmona ...... ination therapy: a case report
@en
P2093
Guangzhi Wang
Yingmin Han
P2860
P304
P356
10.2147/OTT.S170358
P407
P577
2018-01-01T00:00:00Z